Shown: posts 1 to 5 of 5. This is the beginning of the thread.
Posted by kananee on April 25, 2004, at 23:43:41
Has anybody heard about a potential new AD -- perhaps being tested in U.K. -- that's neither an SSRI nor a SNRI but may rely on something called an SP Antagonist? (I have no clue what an SP Antagonist is.)
While searching for info on Effexor side effects and withdrawal symptoms, I saw an abstract for a medical research paper that I couldn't access since I'm not a doc. What interested me was a statement about its (SP Antagonist drug) being used to treat both MDD and IBS.
Thanks.
Posted by chemist on April 26, 2004, at 1:58:42
In reply to SP Antagonist??? Emerging AD???, posted by kananee on April 25, 2004, at 23:43:41
> Has anybody heard about a potential new AD -- perhaps being tested in U.K. -- that's neither an SSRI nor a SNRI but may rely on something called an SP Antagonist? (I have no clue what an SP Antagonist is.)
>
> While searching for info on Effexor side effects and withdrawal symptoms, I saw an abstract for a medical research paper that I couldn't access since I'm not a doc. What interested me was a statement about its (SP Antagonist drug) being used to treat both MDD and IBS.
>
> Thanks.hello, chemist here... SP is substance P, implicated in relief of pain and targeting mu, kappa, omega and (mind going blank) other opiod receptors...)...more later, bed time, and all the best, chemist
Posted by kananee on April 26, 2004, at 2:29:52
In reply to Re: SP Antagonist??? Emerging AD??? » kananee, posted by chemist on April 26, 2004, at 1:58:42
> hello, chemist here... SP is substance P, implicated in relief of pain and targeting mu, kappa, omega and (mind going blank) other opiod receptors...)...more later, bed time, and all the best, chemist
>
Chemist: Thanks for good start. Look forward to learning more when you are rested. (What's an opiod receptor?) You're dealing with pretty much ground zero knowledge here....)
Posted by King Vultan on April 26, 2004, at 12:12:21
In reply to Re: SP Antagonist??? Emerging AD??? » kananee, posted by chemist on April 26, 2004, at 1:58:42
> > Has anybody heard about a potential new AD -- perhaps being tested in U.K. -- that's neither an SSRI nor a SNRI but may rely on something called an SP Antagonist? (I have no clue what an SP Antagonist is.)
> >
> > While searching for info on Effexor side effects and withdrawal symptoms, I saw an abstract for a medical research paper that I couldn't access since I'm not a doc. What interested me was a statement about its (SP Antagonist drug) being used to treat both MDD and IBS.
> >
> > Thanks.
>
> hello, chemist here... SP is substance P, implicated in relief of pain and targeting mu, kappa, omega and (mind going blank) other opiod receptors...)...more later, bed time, and all the best, chemist
>This was widely publicized--don't know if any other drug company is working on a similar drug. The reference to substance P is in the last paragraph.
http://www.usatoday.com/money/industries/health/drugs/2003-11-12-merck_x.htm
Todd
Posted by chemist on April 26, 2004, at 12:46:53
In reply to Re: SP Antagonist??? » chemist, posted by kananee on April 26, 2004, at 2:29:52
>
> > hello, chemist here... SP is substance P, implicated in relief of pain and targeting mu, kappa, omega and (mind going blank) other opiod receptors...)...more later, bed time, and all the best, chemist
> >
> Chemist: Thanks for good start. Look forward to learning more when you are rested. (What's an opiod receptor?) You're dealing with pretty much ground zero knowledge here....)opioid receptors are what are targeted by things like opium and derivatives as well as synthetics. in short, they are the receptors that are involved in the neurotransmission of what we call ``pain.'' codeine, morphine, heroin, fentanyl, and others......more on substance P later......all the best, chemist
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.